Thimerosal hyperpolarizes arterial smooth muscles in an endothelium-dependent manner

Eur J Pharmacol. 1990 Aug 28;185(2-3):235-8. doi: 10.1016/0014-2999(90)90647-o.

Abstract

Thimerosal activates the production of endothelium-derived relaxing factor (EDRF). I examined whether thimerosal also causes the release of an endothelium-dependent hyperpolarizing factor (EDHF). Thimerosal caused an endothelium-dependent hyperpolarization of smooth muscle. This effect is unlikely to be caused by the property of thimerosal to inhibit the acyl-coenzyme A: lysolecithin acyltransferase (LAT) since neither arachidonic acid nor lysolecithin hyperpolarized the muscles. I conclude that thimerosal is not a pure activator of EDRF (nitric oxide) production, but that it also releases a distinct EDHF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Acylglycerophosphocholine O-Acyltransferase / metabolism
  • Animals
  • Arachidonic Acid
  • Arachidonic Acids / pharmacology
  • Coronary Vessels / drug effects
  • Endothelium, Vascular / drug effects*
  • In Vitro Techniques
  • Lysophosphatidylcholines / pharmacology
  • Membrane Potentials / drug effects
  • Muscle, Smooth, Vascular / drug effects*
  • Nitric Oxide / biosynthesis
  • Swine
  • Thimerosal / pharmacology*

Substances

  • Arachidonic Acids
  • Lysophosphatidylcholines
  • Thimerosal
  • Arachidonic Acid
  • Nitric Oxide
  • 1-Acylglycerophosphocholine O-Acyltransferase